Srivastava S - Search Results

1

Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.

Farrell J, Petrovics G, McLeod DG, Srivastava S. Farrell J, et al. Among authors: srivastava s. Int J Mol Sci. 2013 Jul 25;14(8):15510-31. doi: 10.3390/ijms140815510. Int J Mol Sci. 2013. PMID: 23892597 Free PMC article. Review.

2

Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues.

Merseburger AS, Kuczyk MA, Serth J, Bokemeyer C, Young DY, Sun L, Connelly RR, McLeod DG, Mostofi FK, Srivastava SK, Stenzl A, Moul JW, Sesterhenn IA. Merseburger AS, et al. Among authors: srivastava sk. Oncol Rep. 2003 Jan-Feb;10(1):223-8. Oncol Rep. 2003. PMID: 12469173

3

A human novel gene DERPC on 16q22.1 inhibits prostate tumor cell growth and its expression is decreased in prostate and renal tumors.

Sun M, Ma L, Xu L, Li J, Zhang W, Petrovics G, Makarem M, Sesterhenn I, Zhang M, Blanchette-Mackie EJ, Moul J, Srivastava S, Zou Z. Sun M, et al. Among authors: srivastava s. Mol Med. 2002 Oct;8(10):655-63. Mol Med. 2002. PMID: 12477976 Free PMC article.

4

Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells.

Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W, Petrovics G, Sesterhenn IA, McLeod DG, Moul JW, Vahey M, Srivastava S. Segawa T, et al. Among authors: srivastava s. Oncogene. 2002 Dec 12;21(57):8749-58. doi: 10.1038/sj.onc.1205992. Oncogene. 2002. PMID: 12483528

5

A novel neoplastic primary tumor-derived human prostate epithelial cell line.

Ko D, Gu Y, Yasunaga Y, Nakamura K, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Arnstein P, Taylor DO, Hukku B, Rhim JS. Ko D, et al. Among authors: srivastava s. Int J Oncol. 2003 Jun;22(6):1311-7. Int J Oncol. 2003. PMID: 12738999

6

Diagnostic potential of serum proteomic patterns in prostate cancer.

Bañez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL, McLeod DG, Moul JW, Srivastava S. Bañez LL, et al. Among authors: srivastava s. J Urol. 2003 Aug;170(2 Pt 1):442-6. doi: 10.1097/01.ju.0000069431.95404.56. J Urol. 2003. PMID: 12853795 Clinical Trial.

7

Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.

Gao CL, Rawal SK, Sun L, Ali A, Connelly RR, Bañez LL, Sesterhenn IA, McLeod DG, Moul JW, Srivastava S. Gao CL, et al. Among authors: srivastava s. Clin Cancer Res. 2003 Jul;9(7):2545-50. Clin Cancer Res. 2003. PMID: 12855629

8

PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.

Xu LL, Shi Y, Petrovics G, Sun C, Makarem M, Zhang W, Sesterhenn IA, McLeod DG, Sun L, Moul JW, Srivastava S. Xu LL, et al. Among authors: srivastava s. Cancer Res. 2003 Aug 1;63(15):4299-304. Cancer Res. 2003. PMID: 12907594

9

Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.

Petrovics G, Zhang W, Makarem M, Street JP, Connelly R, Sun L, Sesterhenn IA, Srikantan V, Moul JW, Srivastava S. Petrovics G, et al. Among authors: srivastava s. Oncogene. 2004 Jan 15;23(2):605-11. doi: 10.1038/sj.onc.1207069. Oncogene. 2004. PMID: 14724589

10

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

Petrovics G, Liu A, Shaheduzzaman S, Furusato B, Sun C, Chen Y, Nau M, Ravindranath L, Chen Y, Dobi A, Srikantan V, Sesterhenn IA, McLeod DG, Vahey M, Moul JW, Srivastava S. Petrovics G, et al. Among authors: srivastava s. Oncogene. 2005 May 26;24(23):3847-52. doi: 10.1038/sj.onc.1208518. Oncogene. 2005. PMID: 15750627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,130 results

Search Page